|Bid||5.80 x 1200|
|Ask||8.10 x 800|
|Day's range||6.88 - 7.61|
|52-week range||6.88 - 29.81|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
The company whiffed big on its third-quarter earnings as operating expenses continued to rise steeply.
Good afternoon, and thank you for standing by, and welcome to the LifeStance Health third quarter 2021 earnings conference call. While this is my first earnings call with LifeStance, I have been a corporate finance and IR professional for nearly a decade with public healthcare companies.
The trillion-dollar healthcare and energy sectors are undergoing a major transformation, and it will have a lasting impact on the world as we know it